Floatz logo

Valaciclovir

Herpes Simplex 2

New York State Psychiatric InstituteSmall moleculePhase 2Dormant
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
47/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Herpes Simplex 2 cohort.

Asset / SponsorPhaseRating
aciclovir
New York State Psychiatric Institute
Phase 2B

Same molecule, other indications

Valaciclovir is also rated in:

herpes simplex infectious diseaseDormant
BBB
Indicative ·
74 / 100
View asset →
schizoaffective disorderDormant
BB
Indicative ·
68 / 100
View asset →
non-small cell lung carcinomaDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →